GHK-Cu is only part of what’s in the cream.
The ingredient gets the attention. The cream carrying it does some less glamorous work. With GHK-Cu, those details help explain both the interest and the gaps in the research.
First, the copper matters
GHK joins just three amino acids—the units used to build proteins. GHK-Cu is that chain holding copper. Copper Tripeptide-1 is the name you’ll often see on skincare labels. Plain GHK and GHK-Cu aren’t interchangeable names.
A review of GHK skin research reports improvements in skin appearance and fine lines in small studies of face and eye creams. That’s a reason to be interested. It’s also worth knowing how we know: the review points to a conference presentation, a university report and a book chapter, rather than medical-journal papers.
So these are encouraging reports about particular creams. They don’t settle what another bottle will do, even if its label names the same peptide.
Getting into skin is its own job
In a lab study using pieces of human skin, researchers applied a copper-peptide solution. Some copper passed through; some stayed in the tissue. They measured copper, rather than proving that the whole peptide-copper molecule arrived intact.
They also weren’t measuring anyone’s wrinkles. Delivery and a visible benefit are two separate findings. The 2025 topical GHK review still describes skin delivery as a challenge and good clinical studies as scarce.
That leaves a sensible question for any cream claim: was this finished product tested, or just an ingredient somewhere else?
Two studies that are easy to overread
A small study after laser skin treatment found no significant improvement in measured redness, wrinkles or overall skin quality with GHK-Cu skincare. People using it were more satisfied, though. Only 13 people completed the study, so it can’t settle the question for every cream on everyday skin.
The scalp trial often mentioned alongside GHK-Cu didn’t test GHK-Cu at all. It used copper-free GHK with another ingredient, 5-aminolevulinic acid. The men in this small trial had pattern hair loss. The mixture led to greater gains in counted hairs than placebo. Differences in hair length and thickness weren’t statistically significant. A copper-peptide face serum wasn’t tested, so this result doesn’t cover one.
A cream’s safety record doesn’t cover an injection
People in skincare communities report redness, stinging and dryness. These are anecdotes, not reliable measures of how often reactions happen. Small studies can also miss uncommon problems.
For injections, FDA raises a different concern: clumping and impurities may trigger the body’s immune defences. Human safety data are limited. On FDA’s page current as of April 22, 2026, injectable GHK-Cu appears under withdrawn nominations, which isn’t approval or clearance.
Our route comparison keeps these settings separate. Interesting skincare research can stay interesting without becoming an injection recommendation.